These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related]
5. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Kumar B, Dogra S, Kaur I. Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592 [Abstract] [Full Text] [Related]
6. Risk factors for erythema nodosum leprosum. Manandhar R, LeMaster JW, Roche PW. Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [Abstract] [Full Text] [Related]
7. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT. Balagon M, Saunderson PR, Gelber RH. Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929 [Abstract] [Full Text] [Related]
8. Erythema nodosum leprosum on glans penis: unusual manifestation of common disease. Kothiwala SK, Khandpur S, Singh MK, Durgapal P. Int J Dermatol; 2015 Sep; 54(9):1060-3. PubMed ID: 25557912 [Abstract] [Full Text] [Related]
14. Recognizing and managing the immunologic reactions in leprosy. Kamath S, Vaccaro SA, Rea TH, Ochoa MT. J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732 [Abstract] [Full Text] [Related]
15. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient. Suryawati N, Saputra H. Int J Mycobacteriol; 2018 Oct; 7(2):191-194. PubMed ID: 29900900 [Abstract] [Full Text] [Related]
16. Unexplained delayed nerve impairment in leprosy after treatment. Rosenberg NR, Faber WR, Vermeulen M. Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581 [Abstract] [Full Text] [Related]
17. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN. Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695 [Abstract] [Full Text] [Related]
18. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Iyer A, van Eijk M, Silva E, Hatta M, Faber W, Aerts JM, Das PK. Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157 [Abstract] [Full Text] [Related]
19. Histoid leprosy: a retrospective study of 40 cases from India. Kaur I, Dogra S, De D, Saikia UN. Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704 [Abstract] [Full Text] [Related]
20. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Verma KK, Srivastava P, Minz A, Verma K. Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]